WASHINGTON, D.C. – New data from AdvaMed’s COVID-19 Diagnostic Supply Registry reveals that total U.S. shipments of COVID-19 molecular diagnostic tests have reached 160 million. A breakdown of the data shows that innovative diagnostics companies are shipping, on average, 1.2 million molecular tests each day.
Top News
Press Release | September 23, 2020
Press Release | September 22, 2020
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) today announced the launch of a website dedicated to protecting patients from misleading litigation advertising. The Responsible Advertising for Patient Safety website aims to drive and enhance awareness of the dangers of misleading ads for medtech litigation, including a behind-the-scenes look at litigation funding practices of plaintiff attorneys.
Press Release | September 22, 2020
WASHINGTON, D.C. – As part of the medtech industry’s ongoing mobilization to combat COVID-19, the Advanced Medical Technology Association (AdvaMed) today announced that the U.S. Agency for International Development (USAID) has approved a multi-year partnership under which the association will provide private sector resources and expertise to help increase adoption of medical technology-specific international regulatory standards and good regulatory practices by governments across Latin America, Africa, and Southeast Asia.
Events
October
05
October 5, 2020 to October 7, 2020
| The Virtual MedTech Conference will bring together the world's top medtech executives and innovators to network, conduct business, gain access to capital and share insights in an engaging digital... Read More
October to November
22
October 22, 2020 to November 12, 2020
| AdvaMed and Porzio Life Sciences have teamed up to offer a four-part virtual program to help you and your team mitigate the burden of compliance. These interactive programs will provide you with a... Read More
Featured Video
We thank our member companies for their continued efforts to mobilize for health care workers on the frontlines. Learn more about how the industry has come together in the fight against COVID-19.
Industry News
Transitional Pass-Through Payment Reimburses Hospital Outpatient and Ambulatory Surgical Centers for Incremental Cost of AUGMENT in Hindfoot and Ankle Fusion Procedures
Facilitates Medicare Beneficiary Access to AUGMENT by Removing Economic Barrier
AMSTERDAM, The Netherlands, July 20, 2020 (GLOBE NEWSWIRE) -- Wright Medical Group N.V. (NASDAQ: WMGI) today announced that the Centers for Medicare & Medicaid Services (CMS) published an update to the reimbursement calculation used to...
Denver, Colo., June 11, 2020 — The Association of periOperative Registered Nurses (AORN) today announced survey results of more than 1000 surgical nurse leaders in the United States regarding how their facilities are managing the resumption of elective surgeries. The survey results are intended to help medical device manufacturers understand their customers’ pace and product needs as ORs ramp up their efforts to return to full surgical volume. With this information, industry can plan their...
SAN DIEGO, May 27, 2020 /PRNewswire/ -- MVPvets, a 501c(3) nonprofit organization that assists and prepares transitioning military veterans for meaningful employment in life science companies, announced the appointment of new Chairman of its Board of Directors, Capt. Derek Herrera, USMC (Ret.). Herrera has been actively involved as an MVPvets board member since early 2019. He succeeds outgoing Chairman Michael R. Minogue, the Chairman, President and Chief Executive Officer of Abiomed, who has...
BOTHELL, Wash., May 20, 2020 /PRNewswire/ -- FUJIFILM Sonosite, Inc., the world leader in point-of-care ultrasound, has announced Rich Fabian, the company's President and Chief Operating Officer, was appointed to the board of The Advanced Medical Technology Association (AdvaMed), a Washington D.C.-based trade association that leads the effort to advance medical technology in order to achieve healthier lives and healthier economies around the world.
Martinez, CA, USA – March 26, 2020 – Treatment of COVID-19 with ExThera’s Seraph®100 Microbind® Affinity Blood Filter (Seraph 100) has begun in hospitals in Germany and Italy. Seraph 100 treatments of COVID-19 are also expected to begin soon in France and the USA.
Seraph 100 is the only ‘hemoperfusion device’ approved for the reduction of pathogens in blood. In recent EU clinical cases improved lung function and rapid reduction of drug-resistant bacterial pathogens occurred with Seraph 100...
Twitter Feed
September 26, 2020 - 10:45am
We’re honored to announce that leaders from AdvaMed member companies have been nominated for Modern Healthcare’s To… https://t.co/IZEuxA2USu
September 25, 2020 - 11:50am
We’re all feeling isolated and stressed right now. Next week, the Women’s Executive Network and #MedTechCon are gat… https://t.co/mgfLtGy0Wb